The Latin America, Middle East and Africa Deep Brain Stimulation Devices Market is expected to witness market growth of 17.2% CAGR during the forecast period (2019-2025).
The emerging applications of deep brain stimulation technologies for Alzheimer's disease and tinnitus treatment have provided opportunities for both new and existing players in the industry. A major increase in neurologists' use of deep brain stimulators in the treatment of various neurological disorders is complementing market growth in Middle Eastern and African countries.
Growing numbers of patients suffering from dystonia-related involuntary movements, Parkinson's disease, and multiple sclerosis, and growing acceptance of minimally invasive procedures are expected to push market growth exponentially. An increase in the demand for minimally invasive procedures is also a high-impact rendering catalyst for the deep brain stimulation (DBS) devices market due to improved patient outcomes.
Advantages like reduced pain, high cost-effectiveness, safety, efficacy and fast recovery also contribute to increased demand. Factors responsible for replacing open/invasive surgery with minimally invasive surgery are lower incision wounds, better patient satisfaction, shorter hospital stay, postoperative complications and mortality rate. Moreover, the wound healing is quicker, and in conventional treatments the recovery time is longer than that. These advantages are cumulatively responsible for driving market growth for the DBS products.
Based on Applications, the market is segmented into Parkinson's disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder and Other Applications. Based on End User, the market is segmented into Neurological Clinics, Ambulatory Surgical Centers, Hospital and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Functional Neuromodulation, Ltd., Beijing PINS Medical Co., Ltd., NeuroPace, Inc., Nevro Corporation, Neuronetics, Inc., and Fisher Wallace Laboratories, Inc.
Scope of the Study
Market Segmentation:
By Applications
By End User
By Country
Companies Profiled
Unique Offerings from the Publisher
The emerging applications of deep brain stimulation technologies for Alzheimer's disease and tinnitus treatment have provided opportunities for both new and existing players in the industry. A major increase in neurologists' use of deep brain stimulators in the treatment of various neurological disorders is complementing market growth in Middle Eastern and African countries.
Growing numbers of patients suffering from dystonia-related involuntary movements, Parkinson's disease, and multiple sclerosis, and growing acceptance of minimally invasive procedures are expected to push market growth exponentially. An increase in the demand for minimally invasive procedures is also a high-impact rendering catalyst for the deep brain stimulation (DBS) devices market due to improved patient outcomes.
Advantages like reduced pain, high cost-effectiveness, safety, efficacy and fast recovery also contribute to increased demand. Factors responsible for replacing open/invasive surgery with minimally invasive surgery are lower incision wounds, better patient satisfaction, shorter hospital stay, postoperative complications and mortality rate. Moreover, the wound healing is quicker, and in conventional treatments the recovery time is longer than that. These advantages are cumulatively responsible for driving market growth for the DBS products.
Based on Applications, the market is segmented into Parkinson's disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder and Other Applications. Based on End User, the market is segmented into Neurological Clinics, Ambulatory Surgical Centers, Hospital and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Functional Neuromodulation, Ltd., Beijing PINS Medical Co., Ltd., NeuroPace, Inc., Nevro Corporation, Neuronetics, Inc., and Fisher Wallace Laboratories, Inc.
Scope of the Study
Market Segmentation:
By Applications
- Parkinson's disease
- Epilepsy
- Essential Tremor
- Dystonia
- Obsessive Compulsive Disorder
- Other Applications
By End User
- Neurological Clinics
- Ambulatory Surgical Centers
- Hospital and
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- Aleva Neurotherapeutics SA
- Functional Neuromodulation, Ltd.
- Beijing PINS Medical Co., Ltd.
- NeuroPace, Inc.
- Nevro Corporation
- Neuronetics, Inc.
- Fisher Wallace Laboratories, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. LAMEA Deep Brain Stimulation Devices Market by Applications
Chapter 4. LAMEA Deep Brain Stimulation Devices Market by End Users
Chapter 5. LAMEA Deep Brain Stimulation Devices Market by Country
Chapter 6. Company Profiles
Companies Mentioned
- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- Aleva Neurotherapeutics SA
- Functional Neuromodulation, Ltd.
- Beijing PINS Medical Co., Ltd.
- NeuroPace, Inc.
- Nevro Corporation
- Neuronetics, Inc.
- Fisher Wallace Laboratories, Inc.
Methodology
LOADING...
